GT Biopharma, Inc. (NASDAQ:GTBP – Free Report) saw a large growth in short interest during the month of June. As of June 15th, there was short interest totalling 204,600 shares, a growth of 53.5% from the May 31st total of 133,300 shares. Currently, 0.6% of the company’s stock are sold short. Based on an average […]
GT Biopharma, Inc. (NASDAQ:GTBP – Free Report) was the recipient of a large increase in short interest in June. As of June 15th, there was short interest totalling 204,600 shares, an increase of 53.5% from the May 31st total of 133,300 shares. Currently, 0.6% of the company’s stock are short sold. Based on an average […]
China Dongsheng International (OTCMKTS:CDSG – Get Rating) and GT Biopharma (NASDAQ:GTBP – Get Rating) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations and earnings. Analyst Recommendations This is a breakdown of […]
GT Biopharma, Inc. (NASDAQ:GTBP – Get Rating) was the target of a large drop in short interest in May. As of May 31st, there was short interest totalling 133,300 shares, a drop of 5.7% from the May 15th total of 141,400 shares. Approximately 0.4% of the company’s stock are short sold. Based on an average […]